無料セミナー : 2019年11月19日『手術用ロボット:外科医療におけるトランスフォーメーション』 BIS Research共同開催

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

世界のファーマコビジランスおよび医薬品安全性ソフトウェア市場:機能、導入タイプ、エンドユーザー(製薬・バイオテクノロジー企業、CRO、BPO)、地域別 2018年~2024年

Pharmacovigilance and Drug Safety Software Market Size, Share & Trends Analysis Report By Functionality, By Delivery Mode, By End Use (Pharmaceutical & Biotech Companies, CROs, BPOs), And Segment Forecasts, 2018 - 2024

発行 Grand View Research, Inc. 商品コード 374616
出版日 ページ情報 英文 93 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.06円で換算しております。
Back to Top
世界のファーマコビジランスおよび医薬品安全性ソフトウェア市場:機能、導入タイプ、エンドユーザー(製薬・バイオテクノロジー企業、CRO、BPO)、地域別 2018年~2024年 Pharmacovigilance and Drug Safety Software Market Size, Share & Trends Analysis Report By Functionality, By Delivery Mode, By End Use (Pharmaceutical & Biotech Companies, CROs, BPOs), And Segment Forecasts, 2018 - 2024
出版日: 2018年05月08日 ページ情報: 英文 93 Pages
概要

世界のファーマコビジランスおよび医薬品安全性ソフトウェア市場は、2018年から2024年にかけて6.5%のCAGRで推移し、2024年までに2億770万米ドル規模に成長することが予測されています。薬物有害反応(ADR)の発生増加が、当市場の主な成長促進要因となっています。

当レポートでは、世界のファーマコビジランスおよび医薬品安全性ソフトウェア市場を調査し、市場の概要、市場動向、機能・モード・エンドユーザー・地域別の市場動向、市場規模の推移と予測、成長要因・阻害要因の分析、競合情勢、主要企業のプロファイルなど、体系的な情報を提供しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 市場のスナップショット

第4章 市場変数・動向・範囲

  • 市場区分・範囲
  • 成長の見通しマッピング
  • PESTEL分析
  • ファイブフォース分析

第5章 ファーマコビジランス・医薬品安全性ソフトウェア市場:機能別

  • 市場動向の分析:機能別
  • 薬物有害反応(ADR)報告
  • 薬物安全監査
  • 問題追跡
  • 完全統合ソフトウェア

第6章 ファーマコビジランス・医薬品安全性ソフトウェア市場:導入タイプ別

  • 市場動向の分析:導入タイプ別
  • オンプレミス
  • オンデマンド

第7章 ファーマコビジランス・医薬品安全性ソフトウェア市場:エンドユーザー別

  • 市場動向の分析:
  • 製薬・バイオテクノロジー企業
  • CRO(医薬品開発受託機関)
  • BPO(ビジネスプロセスアウトソーシング)
  • その他

第8章 ファーマコビジランス・医薬品安全性ソフトウェア市場:地域別

  • 市場シェア:地域別(実績値・予測値)
  • 北米
  • 欧州
  • アジア太平洋
  • ラテンアメリカ
  • 中東・アフリカ

第9章 競合情勢

  • 企業プロファイル
    • AB cube
    • Max Application
    • Ennov Solutions, Inc.
    • ArisGlobal
    • EXTEDO GmbH
    • Online Business Applications, Inc.
    • Oracle Corporation
    • Sparta Systems, Inc.
    • United BioSource Corporation
    • Relsys
図表

List of Tables

  • TABLE 1 North America pharmacovigilance & drug safety software market, by functionality, 2013 - 2024 (USD Million)
  • TABLE 2 North America pharmacovigilance & drug safety software market, by delivery mode, 2013 - 2024 (USD Million)
  • TABLE 3 North America pharmacovigilance & drug safety software market, by end-use, 2013 - 2024 (USD Million)
  • TABLE 4 U.S. pharmacovigilance & drug safety software market, by functionality, 2013 - 2024 (USD Million)
  • TABLE 5 U.S. pharmacovigilance & drug safety software market, by delivery mode, 2013 - 2024 (USD Million)
  • TABLE 6 U.S. pharmacovigilance & drug safety software market, by end-use, 2013 - 2024 (USD Million)
  • TABLE 7 Canada pharmacovigilance & drug safety software market, by functionality, 2013 - 2024 (USD Million)
  • TABLE 8 Canada pharmacovigilance & drug safety software market, by delivery mode, 2013 - 2024 (USD Million)
  • TABLE 9 Canada pharmacovigilance & drug safety software market, by end-use, 2013 - 2024 (USD Million)
  • TABLE 10 Europe pharmacovigilance & drug safety software market, by functionality, 2013 - 2024 (USD Million)
  • TABLE 11 Europe pharmacovigilance & drug safety software market, by delivery mode, 2013 - 2024 (USD Million)
  • TABLE 12 Europe pharmacovigilance & drug safety software market, by end-use, 2013 - 2024 (USD Million)
  • TABLE 13 UK pharmacovigilance & drug safety software market, by functionality, 2013 - 2024 (USD Million)
  • TABLE 14 UK pharmacovigilance & drug safety software market, by delivery mode, 2013 - 2024 (USD Million)
  • TABLE 15 UK pharmacovigilance & drug safety software market, by end-use, 2013 - 2024 (USD Million)
  • TABLE 16 Germany pharmacovigilance & drug safety software market, by functionality, 2013 - 2024 (USD Million)
  • TABLE 17 Germany pharmacovigilance & drug safety software market, by delivery mode, 2013 - 2024 (USD Million)
  • TABLE 18 Germany pharmacovigilance & drug safety software market, by end-use, 2013 - 2024 (USD Million)
  • TABLE 19 Asia Pacific pharmacovigilance & drug safety software market, by functionality, 2013 - 2024 (USD Million)
  • TABLE 20 Asia Pacific pharmacovigilance & drug safety software market, by delivery mode, 2013 - 2024 (USD Million)
  • TABLE 21 Asia Pacific pharmacovigilance & drug safety software market, by end-use, 2013 - 2024 (USD Million)
  • TABLE 22 Japan pharmacovigilance & drug safety software market, by functionality, 2013 - 2024 (USD Million)
  • TABLE 23 Japan pharmacovigilance & drug safety software market, by delivery mode, 2013 - 2024 (USD Million)
  • TABLE 24 Japan pharmacovigilance & drug safety software market, by end-use, 2013 - 2024 (USD Million)
  • TABLE 25 China pharmacovigilance & drug safety software market, by functionality, 2013 - 2024 (USD Million)
  • TABLE 26 China pharmacovigilance & drug safety software market, by delivery mode, 2013 - 2024 (USD Million)
  • TABLE 27 China pharmacovigilance & drug safety software market, by end-use, 2013 - 2024 (USD Million)
  • TABLE 28 India pharmacovigilance & drug safety software market, by functionality, 2013 - 2024 (USD Million)
  • TABLE 29 India pharmacovigilance & drug safety software market, by delivery mode, 2013 - 2024 (USD Million)
  • TABLE 30 India pharmacovigilance & drug safety software market, by end-use, 2013 - 2024 (USD Million)
  • TABLE 31 Latin America pharmacovigilance & drug safety software market, by functionality, 2013 - 2024 (USD Million)
  • TABLE 32 Latin America pharmacovigilance & drug safety software market, by delivery mode, 2013 - 2024 (USD Million)
  • TABLE 33 Latin America pharmacovigilance & drug safety software market, by end-use, 2013 - 2024 (USD Million)
  • TABLE 34 Brazil pharmacovigilance & drug safety software market, by functionality, 2013 - 2024 (USD Million)
  • TABLE 35 Brazil pharmacovigilance & drug safety software market, by delivery mode, 2013 - 2024 (USD Million)
  • TABLE 36 Brazil pharmacovigilance & drug safety software market, by end-use, 2013 - 2024 (USD Million)
  • TABLE 37 Mexico pharmacovigilance & drug safety software market, by functionality, 2013 - 2024 (USD Million)
  • TABLE 38 Mexico pharmacovigilance & drug safety software market, by delivery mode, 2013 - 2024 (USD Million)
  • TABLE 39 Mexico pharmacovigilance & drug safety software market, by end-use, 2013 - 2024 (USD Million)
  • TABLE 40 MEA pharmacovigilance & drug safety software market, by functionality, 2013 - 2024 (USD Million)
  • TABLE 41 MEA pharmacovigilance & drug safety software market, by delivery mode, 2013 - 2024 (USD Million)
  • TABLE 42 MEA pharmacovigilance & drug safety software market, by end-use, 2013 - 2024 (USD Million)
  • TABLE 43 South Africa pharmacovigilance & drug safety software market, by functionality, 2013 - 2024 (USD Million)
  • TABLE 44 South Africa pharmacovigilance & drug safety software market, by delivery mode, 2013 - 2024 (USD Million)
  • TABLE 45 South Africa pharmacovigilance & drug safety software market, by end-use, 2013 - 2024 (USD Million)

List of Figures

  • FIG. 1 Market summary
  • FIG. 2 Market trends & outlook
  • FIG. 3 Market segmentation & scope
  • FIG. 4 Market driver relevance analysis (Current & future impact)
  • FIG. 5 Per capita health expenditure, USD, (2011 - 2014)
  • FIG. 6 Usage of social media in healthcare.
  • FIG. 7 Market restraint relevance analysis (Current & future impact)
  • FIG. 8 Penetration & Growth Prospect Mapping
  • FIG. 9 Pharmacovigilance & drug safety software software PESTLE Analysis
  • FIG. 10 Porter's Five Forces Analysis
  • FIG. 11 Pharmacovigilance & drug safety software market delivery mode outlook key takeaways
  • FIG. 12 Pharmacovigilance & drug safety software market: Functionality movement analysis
  • FIG. 13 ADR reporting software market, 2013 - 2024 (USD Million)
  • FIG. 14 Drug safety audits market, 2013 - 2024 (USD Million)
  • FIG. 15 Issue tracking market, 2013 - 2024 (USD Million)
  • FIG. 16 Fully integrated software market, 2013 - 2024 (USD Million)
  • FIG. 17 Pharmacovigilance & drug safety software market delivery mode outlook key takeaways
  • FIG. 18 Pharmacovigilance & drug safety software market: Delivery mode movement analysis
  • FIG. 19 On-premise market, 2013 - 2024 (USD Million)
  • FIG. 20 On-demand market, 2013 - 2024 (USD Million)
  • FIG. 21 Pharmacovigilance & drug safety software market end-use outlook: key takeaways
  • FIG. 22 Pharmacovigilance & drug safety software market: End-use movement analysis
  • FIG. 23 Pharma & biotech companies market, 2013 - 2024 (USD Million)
  • FIG. 24 CRO market, 2013 - 2024 (USD Million)
  • FIG. 25 BPO market, 2013 - 2024 (USD Million)
  • FIG. 26 Others market, 2013 - 2024 (USD Million)
  • FIG. 27 Regional market place: Key takeaways
  • FIG. 28 Regional outlook, 2015 & 2024
  • FIG. 29 North America pharmacovigilance & drug safety software market, 2013 - 2024 (USD Million)
  • FIG. 30 U.S. Pharmacovigilance & drug safety software market, 2013 - 2024 (USD Million)
  • FIG. 31 Canada Pharmacovigilance & drug safety software market, 2013 - 2024 (USD Million)
  • FIG. 32 Europe Pharmacovigilance & drug safety software market, 2013 - 2024 (USD Million)
  • FIG. 33 UK Pharmacovigilance & drug safety software market, 2013 - 2024 (USD Million)
  • FIG. 34 Germany Pharmacovigilance & drug safety software market, 2013 - 2024 (USD Million)
  • FIG. 35 Asia Pacific Pharmacovigilance & drug safety software market, 2013 - 2024 (USD Million)
  • FIG. 36 Japan Pharmacovigilance & drug safety software market, 2013 - 2024 (USD Million)
  • FIG. 37 China Pharmacovigilance & drug safety software market, 2013 - 2024 (USD Million)
  • FIG. 38 India Pharmacovigilance & drug safety software market, 2013 - 2024 (USD Million)
  • FIG. 39 Latin America Pharmacovigilance & drug safety software market, 2013 - 2024 (USD Million)
  • FIG. 40 Brazil Pharmacovigilance & drug safety software market, 2013 - 2024 (USD Million)
  • FIG. 41 Mexico Pharmacovigilance & drug safety software market, 2013 - 2024 (USD Million)
  • FIG. 42 MEA Pharmacovigilance & drug safety software market, 2013 - 2024 (USD Million)
  • FIG. 43 South Africa Pharmacovigilance & drug safety software market, 2013 - 2024 (USD Million)
目次
Product Code: GVR-1-68038-144-3

The global pharmacovigilance and drug safety software market size is expected to reach USD 207.7 million by 2024, according to a new report by Grand View Research, Inc., presenting a CAGR of 6.5% during the forecast period. Increasing number of adverse drug reactions (ADR) is a key factor for market growth. ADR imposes a significant burden on research organizations and companies. To curb this problem, pharmaceutical companies are opting for contract outsourcing of these services.

Manufacturers are now striving to identify various ways of cost reduction and minimizing operational expenses by gradually shifting from being fully integrated pharmaceutical companies to sharing costs by collaborating with service providers. Outsourcing helps increase internal resource flexibility, improves timelines, and results in better outcomes in short as well as long terms. Outsourcing also helps achieve better pharmacovigilance (PV) through regulatory compliance, higher quality, better productivity, and improved strategic outcomes.

PV service providers, in an attempt to ensure sustainability, are providing customized and end-to-end solutions to meet consumer needs. These firms are also incorporating integrated technologies such as electronic data capture and hosting of PV warehousing for aggregating cross industry data for benefit risk evaluation. Furthermore, the fact that service providers are now operating via a flexible and variable pricing structure and achieving operational excellence through constant product updates is expected to boost usage rates over the forecast period.

Further key findings from the report suggest:

By functionality, fully integrated software solutions for pharmacovigilance are anticipated to reach USD 25.35 million by 2024, at a CAGR of 7.0% from 2016 to 2024. The ADR reporting software segment, on the other hand, is projected to ascend at a CAGR of 6.4% over the forecast period

Based on delivery mode, the on-demand segment dominated the global pharmacovigilance software market with a share of over 52.0% in 2015

On the basis of end use, the CROs and BPO segments are slated to witness lucrative growth owing to increasing adoption by outsourcing companies to curb healthcare costs

The U.S. PV software market is anticipated to exceed USD 6.45 million by 2024. Asian countries, especially India and China, are also expected to observe remarkable growth in the coming years

The market is relatively competitive in nature thanks to presence of global multinational players. It is also consolidated to a certain extent

Some of the key companies in the market are United BioSource Corporation; Sparta Systems, Inc.; Oracle Corporation; Ennov Solutions Inc.; Max Application; EXTEDO GmbH; AB Cube; Relsys; Online Business Applications, Inc.; and ArisGlobal.

Table of Content

Chapter 1 Research Methodology & Scope

  • 1.1 Region Wise Market Calculation
    • 1.1.1 Region Wise Market: Base Estimates
    • 1.1.2 Global Market: CAGR Calculation
  • 1.2 Region Based Segment Share Calculation
  • 1.3 List of Secondary Sources

Chapter 2 Executive Summary

Chapter 3 Market Snapshot

Chapter 4 Market Variables, Trends& Scope

  • 4.1 Market Segmentation & Scope
    • 4.1.1 Market driver analysis
      • 4.1.1.1 Rising incidences of ADR
      • 4.1.1.2 Globalization of pharmacovigilance
      • 4.1.1.3 Increasing burden from regulatory authorities
      • 4.1.1.4 Introduction of technologically advanced software services
    • 4.1.2 Market restraint analysis
      • 4.1.2.1 Expensive technology
  • 4.2 Penetration & Growth Prospect Mapping
  • 4.3 Pharmacovigilance & Drug Safety Software- PESTLE Analysis
  • 4.4 Industry Analysis - Porter's

Chapter 5 Market Categorization 1: Functionality Estimates & Trend Analysis

  • 5.1 Pharmacovigilance & Drug Safety Software Market: Functionality Movement Analysis
  • 5.2 ADR Reporting Software
    • 5.2.1 ADR reporting software market, 2013 - 2024 (USD Million)
  • 5.3 Drug Safety Audits
    • 5.3.1 Drug safety audits market, 2013 - 2024 (USD Million)
  • 5.4 Issue Tracking
    • 5.4.1 Issue tracking market, 2013 - 2024 (USD Million)
  • 5.5 Fully Integrated Software
    • 5.5.1 Fully integrated software market, 2013 - 2024 (USD Million)

Chapter 6 Market Categorization 2: Delivery Mode Estimates & Trend Analysis

  • 6.1 Pharmacovigilance & Drug Safety Software Market: Delivery Mode Movement Analysis
  • 6.2 On-premise
    • 6.2.1 On-premise market, 2013 - 2024 (USD Million)
  • 6.3 On-demand
    • 6.3.1 On-demand market, 2013 - 2024 (USD Million)

Chapter 7 Market Categorization 3: End-use Estimates & Trend Analysis

  • 7.1 Pharmacovigilance & Drug Safety Software Market: End-use Movement Analysis
  • 7.2 Pharma & Biotech Companies
    • 7.2.1 Pharma & biotech companies market, 2013 - 2024 (USD Million)
  • 7.3 CROs
    • 7.3.1 CROs market, 2013 - 2024 (USD Million)
  • 7.4 BPOs
    • 7.4.1 BPOs market, 2013 - 2024 (USD Million)
  • 7.5 Others
    • 7.5.1 Others market, 2013 - 2024 (USD Million)

Chapter 8 Market Categorization 4: Regional Estimates & Trend Analysis, by Functionality, Delivery Mode, and End-use

  • 8.1 Pharmacovigilance & Drug Safety Software Market Share by Region, 2015 & 2024
  • 8.2 North America
    • 8.2.1 North America pharmacovigilance & drug safety software market, 2013 - 2024 (USD Million)
    • 8.2.2 U.S.
      • 8.2.2.1 U.S. pharmacovigilance & drug safety software market, 2013 - 2024 (USD Million)
    • 8.2.3 Canada
      • 8.2.3.1 Canada pharmacovigilance & drug safety software market, 2013 - 2024 (USD Million)
  • 8.3 Europe
    • 8.3.1 Europe pharmacovigilance & drug safety software market, 2013 - 2024 (USD Million)
    • 8.3.2 UK
      • 8.3.2.1 UK pharmacovigilance & drug safety software market, 2013 - 2024 (USD Million)
    • 8.3.3 Germany
      • 8.3.3.1 Germany pharmacovigilance & drug safety software market, 2013 - 2024 (USD Million)
  • 8.4 Asia Pacific
    • 8.4.1 Asia Pacific pharmacovigilance & drug safety software market, 2013 - 2024 (USD Million)
    • 8.4.2 Japan
      • 8.4.2.1 Japan pharmacovigilance & drug safety software market, 2013 - 2024 (USD Million)
    • 8.4.3 China
      • 8.4.3.1 China pharmacovigilance & drug safety software market, 2013 - 2024 (USD Million)
    • 8.4.4 India
      • 8.4.4.1 India pharmacovigilance & drug safety software market, 2013 - 2024 (USD Million)
  • 8.5 Latin America
    • 8.5.1 Latin America pharmacovigilance & drug safety software market, 2013 - 2024 (USD Million)
    • 8.5.2 Brazil
      • 8.5.2.1 Brazil pharmacovigilance & drug safety software market, 2013 - 2024 (USD Million)
    • 8.5.3 Mexico
      • 8.5.3.1 Mexico pharmacovigilance & drug safety software market, 2013 - 2024 (USD Million)
  • 8.6 MEA
    • 8.6.1 MEA pharmacovigilance & drug safety software market, 2013 - 2024 (USD Million)
    • 8.6.2 South Africa
      • 8.6.2.1 South Africa pharmacovigilance & drug safety software market, 2013 - 2024 (USD Million)

Chapter 9 Competitive Landscape

  • 9.1 Company Profiles
    • 9.1.1 AB cube
      • 9.1.1.1 Company Overview
      • 9.1.1.2 Financial Performance
      • 9.1.1.3 Product Benchmarking
      • 9.1.1.4 Strategic Initiatives
    • 9.1.2 Max Application
      • 9.1.2.1 Company Overview
      • 9.1.2.2 Financial Performance
      • 9.1.2.3 Product Benchmarking
      • 9.1.2.4 Strategic Initiatives
    • 9.1.3 Ennov Solutions, Inc.
      • 9.1.3.1 Company Overview
      • 9.1.3.2 Financial Performance
      • 9.1.3.3 Product Benchmarking
      • 9.1.3.4 Strategic Initiatives
    • 9.1.4 ArisGlobal
      • 9.1.4.1 Company Overview
      • 9.1.4.2 Financial Performance
      • 9.1.4.3 Product Benchmarking
      • 9.1.4.4 Strategic Initiatives
    • 9.1.5 EXTEDO GmbH
      • 9.1.5.1 Company Overview
      • 9.1.5.2 Financial Performance
      • 9.1.5.3 Product Benchmarking
      • 9.1.5.4 Strategic Initiatives
    • 9.1.6 Online Business Applications, Inc.
      • 9.1.6.1 Company Overview
      • 9.1.6.2 Financial Performance
      • 9.1.6.3 Product Benchmarking
      • 9.1.6.4 Strategic Initiatives
    • 9.1.7 Oracle Corporation
      • 9.1.7.1 Company Overview
      • 9.1.7.2 Financial Performance
      • 9.1.7.3 Product Benchmarking
      • 9.1.7.4 Strategic Initiatives
    • 9.1.8 Sparta Systems, Inc.
      • 9.1.8.1 Company Overview
      • 9.1.8.2 Financial Performance
      • 9.1.8.3 Product Benchmarking
      • 9.1.8.4 Strategic Initiatives
    • 9.1.9 United BioSource Corporation
      • 9.1.9.1 Company Overview
      • 9.1.9.2 Financial Performance
      • 9.1.9.3 Product Benchmarking
      • 9.1.9.4 Strategic Initiatives
    • 9.1.10 Relsys
      • 9.1.10.1 Company Overview
      • 9.1.10.2 Financial Performance
      • 9.1.10.3 Product Benchmarking
      • 9.1.10.4 Strategic Initiatives
Back to Top